ADMA Biologics, Inc. (ADMA)

6.55 +0.11 (+1.71%) At close: 04:00PM EDT

ADMA Biologics, Inc.

465 State Route 17
Ramsey, NJ 07446
United States
201 478 5552
https://www.admabiologics.com

Sector(s): Healthcare
Industry: Biotechnology
Full Time Employees: 624

Key Executives

Name	Title	Pay	Exercised	Year Born
Mr. Adam S. Grossman	Co-Founder, President, CEO, Interim CFO & Director	1.59M	N/A	1977
Dr. Jerrold B. Grossman D.P.S., Ph.D.	Co-Founder & Vice Chairman of the Board	90k	N/A	1948
Ms. Kaitlin Kestenberg	COO & Senior VP of Compliance	N/A	N/A	1987
Mr. Drew Pantello	Vice President of Marketing & Corporate Development	N/A	N/A	N/A
Ms. Cindy Petersen	Executive Director of Human Resources	N/A	N/A	N/A
Mr. Skyler Bloom	Senior Director of Business Development & Corporate Strategy	N/A	N/A	N/A

Amounts are as of December 31, 2023 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. The company offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primary humoral immunodeficiency (PI); ASCENIV, an IVIG product for the treatment of PI; and Nabi-HB for the treatment of acute exposure to blood containing Hepatitis B surface antigen and other listed exposures to Hepatitis B. It develops a pipeline of plasma-derived therapeutics, including products related to the methods of treatment and prevention of S. pneumonia infection for an immunoglobulin. In addition, it operates source plasma collection facilities. The company sells its products through independent distributors, drug wholesalers, specialty pharmacies, and other alternate site providers. ADMA Biologics, Inc. was incorporated in 2004 and is headquartered in Ramsey, New Jersey.

Corporate Governance

ADMA Biologics, Inc.’s ISS Governance QualityScore as of April 1, 2024 is 7. The pillar scores are Audit: 7; Board: 7; Shareholder Rights: 8; Compensation: 7.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.